Abstract
Left ventricular hypertrophy is a common manifestation of sustained systemic hypertension and a well-established independent risk factor for adverse cardiovascular events and death. In this paper, we review the analytic methods of measuring left ventricular mass, the recent studies that have defined the scope and strength of the association between increased ventricular mass and prognosis, and some of the clinical trials that have assessed the response of ventricular mass to treatment in patients with hypertension.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
